Atlas Trials

Levetiracetam Extended-Release Plus Stupp Protocol for Hypoxic IDH-Wildtype Glioblastoma

Clinical trial NCT07758062 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07758062
Sponsor
Tianjin Medical University General Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Glioblastoma
Start date
2026-09-01
Primary completion
2029-08-01
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.